Bio-based Material Quarterly Newsletter

In Sept., China's MIIT and the other departments jointly issued an implementation plan for the high-quality development of the raw

materials industry, with the development of bio-based materials listed as one of the primary tasks.

Jindan Technology reported operating revenue and net profit for H1 with huge year-on-year increases and moving forward with a new

PLA project, the designed capacity of which has been scaled up from 10,000 t/a to 75,000 t/a; while Kingfa's net profit tumbled, deferring its plan for putting the 30,000 t/a PLA project into operation.

Zhongke Biotech and Cathay Biotech both delivered remarkable financial performance for H1 2022. The two companies have

been actively setting up production capacities of long-chain dibasic acids (LCDAs) and bio-based polyamides (PAs).

On 16 Aug., Hisun Biomaterials made IPO on the Shanghai's STAR Market, boasting fast-growing revenue and sustainable capacity

improvement of PLA over the past three years.

COFCO Biotech reported a 12.21% year-on-year increase in its net profit for H1 2022, with ongoing initiatives to propel biodegradable

materials PHA, PLA, and lactide projects.

In this Q3, China sees new developments in PLA industry, including projects in Jiangxi Keyuan and Langjing New Material, and the

proposal for 300,000 t/a PLA construction raised by Zhongke Baichuang Environmental Biotechnology (Guantao) Co., Ltd.

In Aug.-Sept., two new bio-based fibre projects were publicised and one bio-based fibre composite project was resubmitted for approval to proceed.

On 6 Sept., BBCA Biochemical published an EIA report (exposure draft) of its 5,000 t/a D-lactic acid industrialisation demonstration

project and the 3,000 t/a PLA industrialisation demonstration project.

On 31 Aug., the EI report of Zhangjiagang Jiutai's 30,000 t/a PTT new bio-based material project was approved.

In Aug., the EI reports for the bio-based new material (bamboo-based cellulose) constructions of Jinzhu New Material and Anhui Huizhu

were posted for public review, the 1st phase of each accounts for capacity of 100,000 t/a.

Bio-based Material Quarterly Newsletter provides you with real-time intelligence on China's biomaterial market.

This newsletter will help you stay ahead of the game in this fast-changing market with real-time reporting on the entire bio-based materials industry chain, from raw materials to end consumption. It includes breaking news from China and abroad, the latest market data (price, import & export, production, consumption, operating rates, etc.), in-depth analysis of market trends, and expert commentary from industry insiders.